The available evidence demonstrated that the drug is not shown to be safe or effective under its conditions of use, according to regulators announcement
Neurotrauma Rep
For the master trial focusing on obesity or overweight, 2,339 eligible adults who had at least one weight-related comorbidity but without diabetes were randomised in a 1:1:1:1 ratio to receive retatrutide in doses of 4 mg, 9 mg, 12 mg, or a placebo
Exploring GLP-1 Agonist Options for Weight Loss Women considering GLP-1 analogs have many medications to choose from
They are regularly triggered by stress, lack of sleep or hormonal factors
Dihexa at a glance Not approved research chemical Type Research compound not approved for human use, never tested in a clinical trial Also called N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, PNB-0408, Angiotensin IV analog Interest in it for Synapse formation, memory, and cognition in animal models of dementia Evidence Animal and lab studies only zero human trials